Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18941101 | SYSTEMS AND METHODS OF ORGANIZING AND RECORDING INTERACTIONS BETWEEN GROUPS OF HEALTHCARE PROVIDERS AND PATIENTS | November 2024 | March 2025 | Allow | 4 | 1 | 0 | Yes | No |
| 18807373 | SYSTEMS AND METHODS OF A MEDICAL DEVICE AND ENVIRONMENTAL CONNECTIVITY HUB | August 2024 | November 2024 | Allow | 3 | 0 | 0 | No | No |
| 18834427 | DIAGNOSTIC LABORATORY SYSTEMS AND METHODS OF IMAGING TUBE ASSEMBLIES | July 2024 | March 2025 | Allow | 8 | 0 | 0 | No | No |
| 18759871 | METHODS AND SYSTEMS FOR GROWING AND RETAINING THE VALUE OF BRAND DRUGS BY COMPUTER PREDICTIVE MODEL | June 2024 | February 2025 | Allow | 8 | 0 | 0 | No | No |
| 18700257 | POPULATION FREQUENCY MODELING FOR QUANTITATIVE VARIANT PATHOGENICITY ESTIMATION | April 2024 | August 2024 | Allow | 5 | 0 | 0 | No | No |
| 18614210 | System and Method for Determining Customer/Patient Wait Times | March 2024 | March 2025 | Allow | 12 | 3 | 0 | Yes | No |
| 18593275 | SYSTEM AND METHOD FOR SECURELY DISPENSING MEDICATION | March 2024 | March 2025 | Allow | 13 | 1 | 0 | Yes | No |
| 18591857 | METHOD FOR INTERPRETING INTER-TUMOR AND INTRA-TUMOR HETEROGENEITY IN SMALL CELL LUNG CANCER | February 2024 | May 2025 | Abandon | 15 | 3 | 0 | No | No |
| 18444507 | PREDICTING FAILURE OF A MEDICAL DEVICE PART USING OPERATIONAL AND NON-OPERATIONAL DATA | February 2024 | July 2025 | Allow | 16 | 0 | 0 | No | No |
| 18424283 | METHOD AND APPARATUS FOR TRACKING FOOD INTAKE BEHAVIORS AND PROVIDING RELEVANT FEEDBACK | January 2024 | May 2025 | Allow | 15 | 1 | 0 | Yes | No |
| 18419798 | Taking Preventative Action in a Secure HIPAA-Compliant Environment with Integrated Hardware and Software and an Intelligent Network, and Systems and Methods Therefor | January 2024 | March 2025 | Allow | 14 | 1 | 0 | No | No |
| 18532572 | METHOD AND APPARATUS FOR OUTPUTTING INFORMATION RELATED TO A PATHOLOGICAL SLIDE IMAGE | December 2023 | October 2024 | Allow | 10 | 1 | 0 | No | No |
| 18342551 | PRECISION TREATMENT WITH MACHINE LEARNING AND DIGITAL TWIN TECHNOLOGY FOR OPTIMAL METABOLIC OUTCOMES | June 2023 | April 2025 | Allow | 22 | 2 | 0 | Yes | No |
| 18199860 | METHOD AND SYSTEM FOR COMPUTER-AIDED DECISION GUIDANCE | May 2023 | April 2025 | Abandon | 23 | 2 | 0 | No | No |
| 18313147 | MEDICATION MANAGEMENT SYSTEMS AND METHODS FOR HEALTH AND HEALTH RELATED FACILITIES | May 2023 | April 2025 | Allow | 23 | 2 | 0 | No | No |
| 18123913 | AUTOMATED PILL DISPENSER | March 2023 | December 2023 | Allow | 9 | 0 | 0 | No | No |
| 18112040 | SYSTEMS AND METHODS FOR PREDICTING ATRIAL ARRHYTHMIA | February 2023 | March 2025 | Allow | 25 | 1 | 0 | Yes | No |
| 18151197 | SYSTEMS AND METHODS FOR CLASSIFYING PATIENTS WITH RESPECT TO MULTIPLE CANCER CLASSES | January 2023 | August 2024 | Allow | 20 | 1 | 0 | Yes | No |
| 18080005 | SYSTEMS AND METHODS FOR INDUCING BEHAVIOR CHANGE | December 2022 | October 2024 | Allow | 22 | 2 | 0 | No | No |
| 18008266 | HEART CONDITION DETECTION SENSOR DEVICE AND SYSTEM FOR PROVIDING COMPLEX LIFE SUPPORT SOLUTION USING SAME | December 2022 | February 2025 | Allow | 26 | 1 | 0 | No | No |
| 18071592 | SYSTEMS AND METHODS FOR MACHINE LEARNING APPROACHES TO MANAGEMENT OF HEALTHCARE POPULATIONS | November 2022 | August 2024 | Allow | 20 | 2 | 0 | Yes | No |
| 17993765 | OPERATING ROOM MANAGEMENT SYSTEM WITH MOBILE APPLICATION | November 2022 | March 2025 | Allow | 28 | 1 | 0 | Yes | No |
| 17985370 | SYSTEMS AND METHODS FOR PATIENT-SPECIFIC DOSING | November 2022 | June 2025 | Abandon | 31 | 2 | 0 | No | Yes |
| 17973948 | SYSTEM AND METHOD FOR GENERATING BRAIN DATA VISUALIZATIONS BASED ON FEDERATED ANALYSIS OF BRAIN DATA IN A COMPLEX COMPUTING NETWORK | October 2022 | April 2025 | Allow | 30 | 0 | 0 | No | No |
| 17958753 | Exercise Metric Algorithm and System for Calculating an Exercise Metric | October 2022 | April 2025 | Abandon | 30 | 1 | 0 | No | No |
| 17910308 | Method For Registering A Virtual Representation Of A Patient Anatomy With A Coordinate System Of A Physical Patient Anatomy | September 2022 | November 2024 | Allow | 26 | 0 | 0 | No | No |
| 17818142 | SYSTEMS AND METHODS FOR PROVIDING VIRTUAL HEALTH SERVICES | August 2022 | November 2024 | Allow | 28 | 2 | 0 | No | No |
| 17881518 | SYSTEM AND METHOD FOR PROVIDING WELLNESS RECOMMENDATION | August 2022 | June 2024 | Allow | 23 | 1 | 0 | Yes | No |
| 17794742 | APPARATUS FOR IMPLEMENTING A CLINICAL PROTOCOL | July 2022 | October 2024 | Allow | 27 | 1 | 0 | No | No |
| 17839832 | SYSTEMS AND METHODS FOR PROVIDING VIRTUAL HEALTH SERVICES | June 2022 | September 2024 | Allow | 27 | 1 | 0 | No | No |
| 17838802 | SYSTEMS AND METHODS FOR PROVIDING VIRTUAL HEALTH SERVICES | June 2022 | October 2024 | Allow | 28 | 2 | 0 | Yes | No |
| 17827521 | Monitoring Remote Smart Devices with Protected Health Information with Integrated Hardware and Software, and Systems and Methods Therefor | May 2022 | September 2024 | Allow | 27 | 0 | 0 | No | No |
| 17711479 | SYSTEM, METHOD, AND APPARATUS FOR ELECTRONIC PATIENT CARE | April 2022 | December 2024 | Allow | 32 | 1 | 0 | No | No |
| 17703465 | METHODS FOR MANAGING DATA FLOW IN LOCALIZED DIAGNOSTICS TESTING SYSTEM | March 2022 | August 2024 | Allow | 28 | 1 | 0 | Yes | No |
| 17700308 | Maintaining User Privacy of Personal, Medical, and Health Care Related Information in Recommendation Systems | March 2022 | August 2024 | Allow | 29 | 1 | 0 | Yes | No |
| 17693194 | METHODS AND SYSTEMS FOR INTERACTIVELY COUNSELING A USER WITH RESPECT TO SUPERVISED CONTENT | March 2022 | March 2025 | Abandon | 36 | 1 | 0 | No | Yes |
| 17390237 | SYSTEMS AND METHODS FOR GENERATING A LIFESTYLE-BASED DISEASE PREVENTION PLAN | July 2021 | February 2025 | Allow | 42 | 2 | 0 | Yes | No |
| 17310236 | PATIENT ID AND SAMPLE ID WORKFLOW METHODS AND APPARATUS FOR FACILITATING DIAGNOSTIC TESTING | July 2021 | August 2024 | Allow | 36 | 2 | 0 | No | No |
| 17207321 | IMPROVING COMPLIANCE OF PATIENT DATA COLLECTION IN CLINICAL TRIALS WITH PREDICTIVE ANALYSIS | March 2021 | December 2024 | Allow | 45 | 1 | 0 | Yes | No |
| 17175618 | Distributed computing system for benefits processing using patient-centric profiling and machine learning | February 2021 | March 2025 | Allow | 49 | 2 | 0 | No | Yes |
| 17267032 | HOSPITAL SYSTEM, SERVER DEVICE, AND METHOD OF MANAGING SCHEDULE | February 2021 | April 2025 | Abandon | 50 | 4 | 0 | No | No |
| 16836575 | MEDICAL INDICATION DETERMINATION USING NEURAL NETWORK PREDICTION ENGINE | March 2020 | July 2024 | Allow | 52 | 3 | 0 | No | No |
| 16774340 | PHARMACEUTICAL PRODUCT AND COMMUNICATION TOOL | January 2020 | January 2025 | Abandon | 60 | 4 | 0 | Yes | Yes |
| 16592112 | METHODS AND APPARATUSES TO VERIFY HOME HEALTH CARE | October 2019 | March 2025 | Abandon | 60 | 4 | 0 | Yes | Yes |
| 16361117 | SYSTEM AND METHOD FOR PROVIDING DENTAL TREATMENT RECOMMENDATIONS | March 2019 | August 2019 | Allow | 5 | 0 | 0 | Yes | No |
| 16270346 | MEDICAL CLAIM DATABASE RELATIONSHIP PROCESSING | February 2019 | October 2019 | Allow | 8 | 1 | 0 | No | No |
| 15356179 | SYSTEM AND METHOD FOR OPTIMIZING NUCLEAR IMAGING APPROPRIATENESS DECISIONS | November 2016 | June 2019 | Allow | 30 | 0 | 0 | No | No |
| 15217451 | EMERGENCY INFORMATION AND IDENTIFICATION DEVICE AND METHOD | July 2016 | October 2019 | Allow | 39 | 2 | 0 | Yes | No |
| 15200795 | SYSTEM AND METHOD FOR PROVIDING DENTAL TREATMENT RECOMMENDATIONS | July 2016 | January 2019 | Allow | 30 | 1 | 0 | Yes | No |
| 15140950 | METHOD AND APPARATUS FOR DYNAMIC CONFIGURATION OF A MULTIPROCESSOR HEALTH DATA SYSTEM | April 2016 | October 2018 | Allow | 30 | 0 | 0 | No | No |
| 14587767 | FACILITATING MEDICATION ADMINISTRATION | December 2014 | May 2018 | Allow | 40 | 1 | 0 | No | No |
| 14079857 | DEVICES, SYSTEMS, AND METHODS FOR AUTOMATED MEDICAL PRODUCT OR SERVICE DELIVERY | November 2013 | August 2017 | Allow | 45 | 4 | 1 | Yes | No |
| 13705421 | EVIDENCE-BASED HEALTHCARE INFORMATION MANAGEMENT PROTOCOLS | December 2012 | September 2019 | Allow | 60 | 12 | 0 | Yes | No |
| 13675440 | Method and System for Acquiring and Evaluating Goal and Outcome Information for Individuals Under Care | November 2012 | January 2016 | Abandon | 38 | 4 | 0 | Yes | Yes |
| 13246060 | METHOD AND APPARATUS FOR DATA MINING COMPOSITE MEDICAL INFORMATION | September 2011 | November 2023 | Abandon | 60 | 8 | 0 | No | Yes |
| 10044357 | PROCESSING AN INSURANCE CLAIM USING ELECTRONIC VERSIONS OF SUPPORTING DOCUMENTS | January 2002 | March 2007 | Allow | 60 | 2 | 0 | Yes | No |
| 10044341 | DELIVERING ELECTRONIC VERSIONS OF SUPPORTING DOCUMENTS ASSOCIATED WITH AN INSURANCE CLAIM | January 2002 | March 2007 | Allow | 60 | 2 | 0 | Yes | No |
| 09947530 | DESIGNING PROGRAM AND METHOD OF FINANCIAL ARTICLE AND RECORDING MEDIUM STORING FINANCIAL ARTICLE DESIGNING PROGRAM | September 2001 | August 2007 | Allow | 60 | 3 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner TOMASZEWSKI, MICHAEL.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner TOMASZEWSKI, MICHAEL works in Art Unit 3681 and has examined 47 patent applications in our dataset. With an allowance rate of 80.9%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 30 months.
Examiner TOMASZEWSKI, MICHAEL's allowance rate of 80.9% places them in the 45% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by TOMASZEWSKI, MICHAEL receive 1.94 office actions before reaching final disposition. This places the examiner in the 62% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by TOMASZEWSKI, MICHAEL is 30 months. This places the examiner in the 43% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +10.4% benefit to allowance rate for applications examined by TOMASZEWSKI, MICHAEL. This interview benefit is in the 47% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 25.0% of applications are subsequently allowed. This success rate is in the 29% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 30.0% of cases where such amendments are filed. This entry rate is in the 35% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 18% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 16.7% of appeals filed. This is in the 1% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 80.0% are granted (fully or in part). This grant rate is in the 92% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 4.3% of allowed cases (in the 87% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 36% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.